Global Human Rabies Immunoglobulin (IM) Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Human Rabies Immunoglobulin (IM) market size is predicted to grow from US$ 329 million in 2025 to US$ 401 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization. In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)
The rising incidence of rabies, especially in developing countries, is a key driver of the human rabies immunoglobulin market. Rabies remains a significant public health concern, particularly in regions where animal vaccination programs are insufficient. Post-exposure prophylaxis (PEP), which includes human rabies immunoglobulin, is critical for preventing the virus after a bite from a rabid animal. Increasing awareness of rabies prevention, government initiatives, and partnerships with international health organizations have boosted demand for human rabies immunoglobulin in both rural and urban areas.
A major challenge in the human rabies immunoglobulin market is its limited availability and high cost, particularly in low- and middle-income countries where rabies is most prevalent. The production of immunoglobulins requires advanced technology and biological materials, making it costly and sometimes scarce in regions with insufficient healthcare infrastructure. Additionally, the need for timely administration after exposure poses logistical difficulties, especially in remote areas, where access to healthcare facilities may be delayed, potentially limiting the effectiveness of the treatment.
Asia-Pacific is expected to experience the highest growth in the market during the forecast period.
LP Information, Inc. (LPI) ' newest research report, the “Human Rabies Immunoglobulin (IM) Industry Forecast” looks at past sales and reviews total world Human Rabies Immunoglobulin (IM) sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Rabies Immunoglobulin (IM) sales for 2025 through 2031. With Human Rabies Immunoglobulin (IM) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Rabies Immunoglobulin (IM) industry.
This Insight Report provides a comprehensive analysis of the global Human Rabies Immunoglobulin (IM) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Rabies Immunoglobulin (IM) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Rabies Immunoglobulin (IM) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Rabies Immunoglobulin (IM) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Rabies Immunoglobulin (IM).
This report presents a comprehensive overview, market shares, and growth opportunities of Human Rabies Immunoglobulin (IM) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Human Rabies Immunoglobulin (IM) market?
What factors are driving Human Rabies Immunoglobulin (IM) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Rabies Immunoglobulin (IM) market opportunities vary by end market size?
How does Human Rabies Immunoglobulin (IM) break out by Type, by Application?
The global Human Rabies Immunoglobulin (IM) market size is predicted to grow from US$ 329 million in 2025 to US$ 401 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization. In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)
The rising incidence of rabies, especially in developing countries, is a key driver of the human rabies immunoglobulin market. Rabies remains a significant public health concern, particularly in regions where animal vaccination programs are insufficient. Post-exposure prophylaxis (PEP), which includes human rabies immunoglobulin, is critical for preventing the virus after a bite from a rabid animal. Increasing awareness of rabies prevention, government initiatives, and partnerships with international health organizations have boosted demand for human rabies immunoglobulin in both rural and urban areas.
A major challenge in the human rabies immunoglobulin market is its limited availability and high cost, particularly in low- and middle-income countries where rabies is most prevalent. The production of immunoglobulins requires advanced technology and biological materials, making it costly and sometimes scarce in regions with insufficient healthcare infrastructure. Additionally, the need for timely administration after exposure poses logistical difficulties, especially in remote areas, where access to healthcare facilities may be delayed, potentially limiting the effectiveness of the treatment.
Asia-Pacific is expected to experience the highest growth in the market during the forecast period.
LP Information, Inc. (LPI) ' newest research report, the “Human Rabies Immunoglobulin (IM) Industry Forecast” looks at past sales and reviews total world Human Rabies Immunoglobulin (IM) sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Rabies Immunoglobulin (IM) sales for 2025 through 2031. With Human Rabies Immunoglobulin (IM) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Rabies Immunoglobulin (IM) industry.
This Insight Report provides a comprehensive analysis of the global Human Rabies Immunoglobulin (IM) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Rabies Immunoglobulin (IM) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Rabies Immunoglobulin (IM) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Rabies Immunoglobulin (IM) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Rabies Immunoglobulin (IM).
This report presents a comprehensive overview, market shares, and growth opportunities of Human Rabies Immunoglobulin (IM) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- ERIG
- HRIG
- Category II Exposure
- Category III Exposure
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL Behring
- Grifols
- Sanofi
- Sichuan Yuanda Shuyang
- Tiantan Bio
- Kamada
- CBPO
- Shuanglin Bio
- Weiguang Bio
- Shanghai RAAS
- Bharat Serum
- VINS
What is the 10-year outlook for the global Human Rabies Immunoglobulin (IM) market?
What factors are driving Human Rabies Immunoglobulin (IM) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Rabies Immunoglobulin (IM) market opportunities vary by end market size?
How does Human Rabies Immunoglobulin (IM) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Rabies Immunoglobulin (IM) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Rabies Immunoglobulin (IM) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Rabies Immunoglobulin (IM) by Country/Region, 2020, 2024 & 2031
2.2 Human Rabies Immunoglobulin (IM) Segment by Type
2.2.1 ERIG
2.2.2 HRIG
2.3 Human Rabies Immunoglobulin (IM) Sales by Type
2.3.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
2.3.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Type (2020-2025)
2.4 Human Rabies Immunoglobulin (IM) Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Human Rabies Immunoglobulin (IM) Sales by Application
2.5.1 Global Human Rabies Immunoglobulin (IM) Sale Market Share by Application (2020-2025)
2.5.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Rabies Immunoglobulin (IM) Breakdown Data by Company
3.1.1 Global Human Rabies Immunoglobulin (IM) Annual Sales by Company (2020-2025)
3.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2020-2025)
3.2 Global Human Rabies Immunoglobulin (IM) Annual Revenue by Company (2020-2025)
3.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025)
3.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2020-2025)
3.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Company
3.4 Key Manufacturers Human Rabies Immunoglobulin (IM) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Rabies Immunoglobulin (IM) Product Location Distribution
3.4.2 Players Human Rabies Immunoglobulin (IM) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN RABIES IMMUNOGLOBULIN (IM) BY GEOGRAPHIC REGION
4.1 World Historic Human Rabies Immunoglobulin (IM) Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Rabies Immunoglobulin (IM) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Rabies Immunoglobulin (IM) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Rabies Immunoglobulin (IM) Market Size by Country/Region (2020-2025)
4.2.1 Global Human Rabies Immunoglobulin (IM) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Rabies Immunoglobulin (IM) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Rabies Immunoglobulin (IM) Sales Growth
4.4 APAC Human Rabies Immunoglobulin (IM) Sales Growth
4.5 Europe Human Rabies Immunoglobulin (IM) Sales Growth
4.6 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Growth
5 AMERICAS
5.1 Americas Human Rabies Immunoglobulin (IM) Sales by Country
5.1.1 Americas Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025)
5.1.2 Americas Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025)
5.2 Americas Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
5.3 Americas Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Rabies Immunoglobulin (IM) Sales by Region
6.1.1 APAC Human Rabies Immunoglobulin (IM) Sales by Region (2020-2025)
6.1.2 APAC Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2025)
6.2 APAC Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
6.3 APAC Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Rabies Immunoglobulin (IM) by Country
7.1.1 Europe Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025)
7.1.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025)
7.2 Europe Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
7.3 Europe Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Rabies Immunoglobulin (IM) by Country
8.1.1 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
8.3 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Rabies Immunoglobulin (IM)
10.3 Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
10.4 Industry Chain Structure of Human Rabies Immunoglobulin (IM)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Rabies Immunoglobulin (IM) Distributors
11.3 Human Rabies Immunoglobulin (IM) Customer
12 WORLD FORECAST REVIEW FOR HUMAN RABIES IMMUNOGLOBULIN (IM) BY GEOGRAPHIC REGION
12.1 Global Human Rabies Immunoglobulin (IM) Market Size Forecast by Region
12.1.1 Global Human Rabies Immunoglobulin (IM) Forecast by Region (2026-2031)
12.1.2 Global Human Rabies Immunoglobulin (IM) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Rabies Immunoglobulin (IM) Forecast by Type (2026-2031)
12.7 Global Human Rabies Immunoglobulin (IM) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sichuan Yuanda Shuyang
13.4.1 Sichuan Yuanda Shuyang Company Information
13.4.2 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sichuan Yuanda Shuyang Main Business Overview
13.4.5 Sichuan Yuanda Shuyang Latest Developments
13.5 Tiantan Bio
13.5.1 Tiantan Bio Company Information
13.5.2 Tiantan Bio Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.5.3 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Tiantan Bio Main Business Overview
13.5.5 Tiantan Bio Latest Developments
13.6 Kamada
13.6.1 Kamada Company Information
13.6.2 Kamada Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Kamada Main Business Overview
13.6.5 Kamada Latest Developments
13.7 CBPO
13.7.1 CBPO Company Information
13.7.2 CBPO Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 CBPO Main Business Overview
13.7.5 CBPO Latest Developments
13.8 Shuanglin Bio
13.8.1 Shuanglin Bio Company Information
13.8.2 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Shuanglin Bio Main Business Overview
13.8.5 Shuanglin Bio Latest Developments
13.9 Weiguang Bio
13.9.1 Weiguang Bio Company Information
13.9.2 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Weiguang Bio Main Business Overview
13.9.5 Weiguang Bio Latest Developments
13.10 Shanghai RAAS
13.10.1 Shanghai RAAS Company Information
13.10.2 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Shanghai RAAS Main Business Overview
13.10.5 Shanghai RAAS Latest Developments
13.11 Bharat Serum
13.11.1 Bharat Serum Company Information
13.11.2 Bharat Serum Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bharat Serum Main Business Overview
13.11.5 Bharat Serum Latest Developments
13.12 VINS
13.12.1 VINS Company Information
13.12.2 VINS Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 VINS Main Business Overview
13.12.5 VINS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Rabies Immunoglobulin (IM) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Rabies Immunoglobulin (IM) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Rabies Immunoglobulin (IM) by Country/Region, 2020, 2024 & 2031
2.2 Human Rabies Immunoglobulin (IM) Segment by Type
2.2.1 ERIG
2.2.2 HRIG
2.3 Human Rabies Immunoglobulin (IM) Sales by Type
2.3.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
2.3.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Type (2020-2025)
2.4 Human Rabies Immunoglobulin (IM) Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Human Rabies Immunoglobulin (IM) Sales by Application
2.5.1 Global Human Rabies Immunoglobulin (IM) Sale Market Share by Application (2020-2025)
2.5.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Rabies Immunoglobulin (IM) Breakdown Data by Company
3.1.1 Global Human Rabies Immunoglobulin (IM) Annual Sales by Company (2020-2025)
3.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2020-2025)
3.2 Global Human Rabies Immunoglobulin (IM) Annual Revenue by Company (2020-2025)
3.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025)
3.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2020-2025)
3.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Company
3.4 Key Manufacturers Human Rabies Immunoglobulin (IM) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Rabies Immunoglobulin (IM) Product Location Distribution
3.4.2 Players Human Rabies Immunoglobulin (IM) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN RABIES IMMUNOGLOBULIN (IM) BY GEOGRAPHIC REGION
4.1 World Historic Human Rabies Immunoglobulin (IM) Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Rabies Immunoglobulin (IM) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Rabies Immunoglobulin (IM) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Rabies Immunoglobulin (IM) Market Size by Country/Region (2020-2025)
4.2.1 Global Human Rabies Immunoglobulin (IM) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Rabies Immunoglobulin (IM) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Rabies Immunoglobulin (IM) Sales Growth
4.4 APAC Human Rabies Immunoglobulin (IM) Sales Growth
4.5 Europe Human Rabies Immunoglobulin (IM) Sales Growth
4.6 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Growth
5 AMERICAS
5.1 Americas Human Rabies Immunoglobulin (IM) Sales by Country
5.1.1 Americas Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025)
5.1.2 Americas Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025)
5.2 Americas Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
5.3 Americas Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Rabies Immunoglobulin (IM) Sales by Region
6.1.1 APAC Human Rabies Immunoglobulin (IM) Sales by Region (2020-2025)
6.1.2 APAC Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2025)
6.2 APAC Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
6.3 APAC Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Rabies Immunoglobulin (IM) by Country
7.1.1 Europe Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025)
7.1.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025)
7.2 Europe Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
7.3 Europe Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Rabies Immunoglobulin (IM) by Country
8.1.1 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
8.3 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Rabies Immunoglobulin (IM)
10.3 Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
10.4 Industry Chain Structure of Human Rabies Immunoglobulin (IM)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Rabies Immunoglobulin (IM) Distributors
11.3 Human Rabies Immunoglobulin (IM) Customer
12 WORLD FORECAST REVIEW FOR HUMAN RABIES IMMUNOGLOBULIN (IM) BY GEOGRAPHIC REGION
12.1 Global Human Rabies Immunoglobulin (IM) Market Size Forecast by Region
12.1.1 Global Human Rabies Immunoglobulin (IM) Forecast by Region (2026-2031)
12.1.2 Global Human Rabies Immunoglobulin (IM) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Rabies Immunoglobulin (IM) Forecast by Type (2026-2031)
12.7 Global Human Rabies Immunoglobulin (IM) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sichuan Yuanda Shuyang
13.4.1 Sichuan Yuanda Shuyang Company Information
13.4.2 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sichuan Yuanda Shuyang Main Business Overview
13.4.5 Sichuan Yuanda Shuyang Latest Developments
13.5 Tiantan Bio
13.5.1 Tiantan Bio Company Information
13.5.2 Tiantan Bio Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.5.3 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Tiantan Bio Main Business Overview
13.5.5 Tiantan Bio Latest Developments
13.6 Kamada
13.6.1 Kamada Company Information
13.6.2 Kamada Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Kamada Main Business Overview
13.6.5 Kamada Latest Developments
13.7 CBPO
13.7.1 CBPO Company Information
13.7.2 CBPO Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 CBPO Main Business Overview
13.7.5 CBPO Latest Developments
13.8 Shuanglin Bio
13.8.1 Shuanglin Bio Company Information
13.8.2 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Shuanglin Bio Main Business Overview
13.8.5 Shuanglin Bio Latest Developments
13.9 Weiguang Bio
13.9.1 Weiguang Bio Company Information
13.9.2 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Weiguang Bio Main Business Overview
13.9.5 Weiguang Bio Latest Developments
13.10 Shanghai RAAS
13.10.1 Shanghai RAAS Company Information
13.10.2 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Shanghai RAAS Main Business Overview
13.10.5 Shanghai RAAS Latest Developments
13.11 Bharat Serum
13.11.1 Bharat Serum Company Information
13.11.2 Bharat Serum Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bharat Serum Main Business Overview
13.11.5 Bharat Serum Latest Developments
13.12 VINS
13.12.1 VINS Company Information
13.12.2 VINS Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
13.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 VINS Main Business Overview
13.12.5 VINS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Rabies Immunoglobulin (IM) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Rabies Immunoglobulin (IM) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of ERIG
Table 4. Major Players of HRIG
Table 5. Global Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 6. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Table 7. Global Human Rabies Immunoglobulin (IM) Revenue by Type (2020-2025) & ($ million)
Table 8. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2020-2025)
Table 9. Global Human Rabies Immunoglobulin (IM) Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Human Rabies Immunoglobulin (IM) Sale by Application (2020-2025) & (K Units)
Table 11. Global Human Rabies Immunoglobulin (IM) Sale Market Share by Application (2020-2025)
Table 12. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2020-2025) & ($ million)
Table 13. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2020-2025)
Table 14. Global Human Rabies Immunoglobulin (IM) Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025) & (K Units)
Table 16. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2020-2025)
Table 17. Global Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2020-2025)
Table 19. Global Human Rabies Immunoglobulin (IM) Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Human Rabies Immunoglobulin (IM) Producing Area Distribution and Sales Area
Table 21. Players Human Rabies Immunoglobulin (IM) Products Offered
Table 22. Human Rabies Immunoglobulin (IM) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Rabies Immunoglobulin (IM) Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Human Rabies Immunoglobulin (IM) Sales Market Share Geographic Region (2020-2025)
Table 27. Global Human Rabies Immunoglobulin (IM) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Human Rabies Immunoglobulin (IM) Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Country/Region (2020-2025)
Table 31. Global Human Rabies Immunoglobulin (IM) Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 34. Americas Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2025)
Table 35. Americas Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 37. Americas Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 38. APAC Human Rabies Immunoglobulin (IM) Sales by Region (2020-2025) & (K Units)
Table 39. APAC Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2020-2025)
Table 40. APAC Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 42. APAC Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 43. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 44. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 46. Europe Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Human Rabies Immunoglobulin (IM)
Table 52. Key Market Challenges & Risks of Human Rabies Immunoglobulin (IM)
Table 53. Key Industry Trends of Human Rabies Immunoglobulin (IM)
Table 54. Human Rabies Immunoglobulin (IM) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Rabies Immunoglobulin (IM) Distributors List
Table 57. Human Rabies Immunoglobulin (IM) Customer List
Table 58. Global Human Rabies Immunoglobulin (IM) Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Human Rabies Immunoglobulin (IM) Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Human Rabies Immunoglobulin (IM) Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Human Rabies Immunoglobulin (IM) Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Human Rabies Immunoglobulin (IM) Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Human Rabies Immunoglobulin (IM) Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Human Rabies Immunoglobulin (IM) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Human Rabies Immunoglobulin (IM) Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Human Rabies Immunoglobulin (IM) Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. CSL Behring Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 73. CSL Behring Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 74. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. CSL Behring Main Business
Table 76. CSL Behring Latest Developments
Table 77. Grifols Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 78. Grifols Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 79. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Grifols Main Business
Table 81. Grifols Latest Developments
Table 82. Sanofi Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 84. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Sichuan Yuanda Shuyang Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 88. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 89. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Sichuan Yuanda Shuyang Main Business
Table 91. Sichuan Yuanda Shuyang Latest Developments
Table 92. Tiantan Bio Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 93. Tiantan Bio Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 94. Tiantan Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Tiantan Bio Main Business
Table 96. Tiantan Bio Latest Developments
Table 97. Kamada Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 98. Kamada Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 99. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Kamada Main Business
Table 101. Kamada Latest Developments
Table 102. CBPO Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 103. CBPO Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 104. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. CBPO Main Business
Table 106. CBPO Latest Developments
Table 107. Shuanglin Bio Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 108. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 109. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Shuanglin Bio Main Business
Table 111. Shuanglin Bio Latest Developments
Table 112. Weiguang Bio Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 113. Weiguang Bio Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 114. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Weiguang Bio Main Business
Table 116. Weiguang Bio Latest Developments
Table 117. Shanghai RAAS Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 118. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 119. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Shanghai RAAS Main Business
Table 121. Shanghai RAAS Latest Developments
Table 122. Bharat Serum Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 123. Bharat Serum Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 124. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Bharat Serum Main Business
Table 126. Bharat Serum Latest Developments
Table 127. VINS Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 128. VINS Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 129. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. VINS Main Business
Table 131. VINS Latest Developments
Table 1. Human Rabies Immunoglobulin (IM) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Rabies Immunoglobulin (IM) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of ERIG
Table 4. Major Players of HRIG
Table 5. Global Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 6. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Table 7. Global Human Rabies Immunoglobulin (IM) Revenue by Type (2020-2025) & ($ million)
Table 8. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2020-2025)
Table 9. Global Human Rabies Immunoglobulin (IM) Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Human Rabies Immunoglobulin (IM) Sale by Application (2020-2025) & (K Units)
Table 11. Global Human Rabies Immunoglobulin (IM) Sale Market Share by Application (2020-2025)
Table 12. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2020-2025) & ($ million)
Table 13. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2020-2025)
Table 14. Global Human Rabies Immunoglobulin (IM) Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025) & (K Units)
Table 16. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2020-2025)
Table 17. Global Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2020-2025)
Table 19. Global Human Rabies Immunoglobulin (IM) Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Human Rabies Immunoglobulin (IM) Producing Area Distribution and Sales Area
Table 21. Players Human Rabies Immunoglobulin (IM) Products Offered
Table 22. Human Rabies Immunoglobulin (IM) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Rabies Immunoglobulin (IM) Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Human Rabies Immunoglobulin (IM) Sales Market Share Geographic Region (2020-2025)
Table 27. Global Human Rabies Immunoglobulin (IM) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Human Rabies Immunoglobulin (IM) Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Country/Region (2020-2025)
Table 31. Global Human Rabies Immunoglobulin (IM) Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 34. Americas Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2025)
Table 35. Americas Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 37. Americas Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 38. APAC Human Rabies Immunoglobulin (IM) Sales by Region (2020-2025) & (K Units)
Table 39. APAC Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2020-2025)
Table 40. APAC Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 42. APAC Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 43. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 44. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 46. Europe Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Human Rabies Immunoglobulin (IM)
Table 52. Key Market Challenges & Risks of Human Rabies Immunoglobulin (IM)
Table 53. Key Industry Trends of Human Rabies Immunoglobulin (IM)
Table 54. Human Rabies Immunoglobulin (IM) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Rabies Immunoglobulin (IM) Distributors List
Table 57. Human Rabies Immunoglobulin (IM) Customer List
Table 58. Global Human Rabies Immunoglobulin (IM) Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Human Rabies Immunoglobulin (IM) Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Human Rabies Immunoglobulin (IM) Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Human Rabies Immunoglobulin (IM) Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Human Rabies Immunoglobulin (IM) Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Human Rabies Immunoglobulin (IM) Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Human Rabies Immunoglobulin (IM) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Human Rabies Immunoglobulin (IM) Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Human Rabies Immunoglobulin (IM) Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. CSL Behring Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 73. CSL Behring Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 74. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. CSL Behring Main Business
Table 76. CSL Behring Latest Developments
Table 77. Grifols Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 78. Grifols Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 79. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Grifols Main Business
Table 81. Grifols Latest Developments
Table 82. Sanofi Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 84. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Sichuan Yuanda Shuyang Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 88. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 89. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Sichuan Yuanda Shuyang Main Business
Table 91. Sichuan Yuanda Shuyang Latest Developments
Table 92. Tiantan Bio Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 93. Tiantan Bio Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 94. Tiantan Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Tiantan Bio Main Business
Table 96. Tiantan Bio Latest Developments
Table 97. Kamada Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 98. Kamada Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 99. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Kamada Main Business
Table 101. Kamada Latest Developments
Table 102. CBPO Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 103. CBPO Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 104. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. CBPO Main Business
Table 106. CBPO Latest Developments
Table 107. Shuanglin Bio Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 108. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 109. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Shuanglin Bio Main Business
Table 111. Shuanglin Bio Latest Developments
Table 112. Weiguang Bio Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 113. Weiguang Bio Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 114. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Weiguang Bio Main Business
Table 116. Weiguang Bio Latest Developments
Table 117. Shanghai RAAS Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 118. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 119. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Shanghai RAAS Main Business
Table 121. Shanghai RAAS Latest Developments
Table 122. Bharat Serum Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 123. Bharat Serum Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 124. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Bharat Serum Main Business
Table 126. Bharat Serum Latest Developments
Table 127. VINS Basic Information, Human Rabies Immunoglobulin (IM) Manufacturing Base, Sales Area and Its Competitors
Table 128. VINS Human Rabies Immunoglobulin (IM) Product Portfolios and Specifications
Table 129. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. VINS Main Business
Table 131. VINS Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Rabies Immunoglobulin (IM)
Figure 2. Human Rabies Immunoglobulin (IM) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Rabies Immunoglobulin (IM) Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Rabies Immunoglobulin (IM) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Rabies Immunoglobulin (IM) Sales Market Share by Country/Region (2024)
Figure 10. Human Rabies Immunoglobulin (IM) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of ERIG
Figure 12. Product Picture of HRIG
Figure 13. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2025
Figure 14. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2020-2025)
Figure 15. Human Rabies Immunoglobulin (IM) Consumed in Category II Exposure
Figure 16. Global Human Rabies Immunoglobulin (IM) Market: Category II Exposure (2020-2025) & (K Units)
Figure 17. Human Rabies Immunoglobulin (IM) Consumed in Category III Exposure
Figure 18. Global Human Rabies Immunoglobulin (IM) Market: Category III Exposure (2020-2025) & (K Units)
Figure 19. Global Human Rabies Immunoglobulin (IM) Sale Market Share by Application (2024)
Figure 20. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application in 2025
Figure 21. Human Rabies Immunoglobulin (IM) Sales by Company in 2025 (K Units)
Figure 22. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Company in 2025
Figure 23. Human Rabies Immunoglobulin (IM) Revenue by Company in 2025 ($ millions)
Figure 24. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Company in 2025
Figure 25. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Human Rabies Immunoglobulin (IM) Sales 2020-2025 (K Units)
Figure 28. Americas Human Rabies Immunoglobulin (IM) Revenue 2020-2025 ($ millions)
Figure 29. APAC Human Rabies Immunoglobulin (IM) Sales 2020-2025 (K Units)
Figure 30. APAC Human Rabies Immunoglobulin (IM) Revenue 2020-2025 ($ millions)
Figure 31. Europe Human Rabies Immunoglobulin (IM) Sales 2020-2025 (K Units)
Figure 32. Europe Human Rabies Immunoglobulin (IM) Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue 2020-2025 ($ millions)
Figure 35. Americas Human Rabies Immunoglobulin (IM) Sales Market Share by Country in 2025
Figure 36. Americas Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2025)
Figure 37. Americas Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 38. Americas Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 39. United States Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Human Rabies Immunoglobulin (IM) Sales Market Share by Region in 2025
Figure 44. APAC Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2020-2025)
Figure 45. APAC Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 46. APAC Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 47. China Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 51. India Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Country in 2025
Figure 55. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2025)
Figure 56. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 57. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 58. Germany Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 59. France Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 66. Egypt Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Human Rabies Immunoglobulin (IM) in 2025
Figure 72. Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
Figure 73. Industry Chain Structure of Human Rabies Immunoglobulin (IM)
Figure 74. Channels of Distribution
Figure 75. Global Human Rabies Immunoglobulin (IM) Sales Market Forecast by Region (2026-2031)
Figure 76. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Human Rabies Immunoglobulin (IM)
Figure 2. Human Rabies Immunoglobulin (IM) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Rabies Immunoglobulin (IM) Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Rabies Immunoglobulin (IM) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Rabies Immunoglobulin (IM) Sales Market Share by Country/Region (2024)
Figure 10. Human Rabies Immunoglobulin (IM) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of ERIG
Figure 12. Product Picture of HRIG
Figure 13. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2025
Figure 14. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2020-2025)
Figure 15. Human Rabies Immunoglobulin (IM) Consumed in Category II Exposure
Figure 16. Global Human Rabies Immunoglobulin (IM) Market: Category II Exposure (2020-2025) & (K Units)
Figure 17. Human Rabies Immunoglobulin (IM) Consumed in Category III Exposure
Figure 18. Global Human Rabies Immunoglobulin (IM) Market: Category III Exposure (2020-2025) & (K Units)
Figure 19. Global Human Rabies Immunoglobulin (IM) Sale Market Share by Application (2024)
Figure 20. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application in 2025
Figure 21. Human Rabies Immunoglobulin (IM) Sales by Company in 2025 (K Units)
Figure 22. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Company in 2025
Figure 23. Human Rabies Immunoglobulin (IM) Revenue by Company in 2025 ($ millions)
Figure 24. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Company in 2025
Figure 25. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Human Rabies Immunoglobulin (IM) Sales 2020-2025 (K Units)
Figure 28. Americas Human Rabies Immunoglobulin (IM) Revenue 2020-2025 ($ millions)
Figure 29. APAC Human Rabies Immunoglobulin (IM) Sales 2020-2025 (K Units)
Figure 30. APAC Human Rabies Immunoglobulin (IM) Revenue 2020-2025 ($ millions)
Figure 31. Europe Human Rabies Immunoglobulin (IM) Sales 2020-2025 (K Units)
Figure 32. Europe Human Rabies Immunoglobulin (IM) Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue 2020-2025 ($ millions)
Figure 35. Americas Human Rabies Immunoglobulin (IM) Sales Market Share by Country in 2025
Figure 36. Americas Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2025)
Figure 37. Americas Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 38. Americas Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 39. United States Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Human Rabies Immunoglobulin (IM) Sales Market Share by Region in 2025
Figure 44. APAC Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2020-2025)
Figure 45. APAC Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 46. APAC Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 47. China Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 51. India Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Country in 2025
Figure 55. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2025)
Figure 56. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 57. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 58. Germany Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 59. France Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 66. Egypt Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Human Rabies Immunoglobulin (IM) Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Human Rabies Immunoglobulin (IM) in 2025
Figure 72. Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
Figure 73. Industry Chain Structure of Human Rabies Immunoglobulin (IM)
Figure 74. Channels of Distribution
Figure 75. Global Human Rabies Immunoglobulin (IM) Sales Market Forecast by Region (2026-2031)
Figure 76. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Application (2026-2031)
